Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,269.9
-8.0 (-0.24%)

 

  • STI Straits Times Index
    3,269.9
    -8.0 (-0.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,721.4
    -9.3 (-0.54%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,816.3
    186.4 (0.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,804.2
    52.4 (1.91%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,425.5
    -38.7 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,501.4
    -36.4 (-0.56%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,230.5
    1.8 (0.08%)
    Index delayed 20 minutes
  • XAO XAO
    6,241.9
    27.3 (0.44%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 900.8M
  • Value: 1,217.8M
  • Rise: 182
  • Fall: 158
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing1.070-0.040
RHT HealthTrust0.014-0.001
Rex Intl0.091+0.002
Ezion0.044+0.002
ThaiBev0.815+0.015
Hi-P1.140+0.090
Golden Agri-Res0.285+0.015
AEM1.070+0.050
HPH Trust USD0.235-0.005
Mapletree Log Tr1.400+0.020

World Indices

World Indices
Name Last Change
Nasdaq 7,527.6 +67.8
HSI 28,816.3 +186.4
HSCEI 11,427.3 +121.3
Jakarta 6,501.4 -36.4
Nikkei 225 21,425.5 -38.7
SSE Comp 2,804.2 +52.4
Shanghai A 2,936.8 +55.0
Shanghai B 289.6 +3.0
ShenZhen A 1,544.7 +34.5
ShenZhen B 952.9 +9.0
Taiwan W 10,322.9 +3.4
PSE Comp 0.0
KOSPI 2,230.5 +1.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Annica ANNICA HOLDINGS LIMITED
Quotes 10 Minutes Delayed. Updated at 22 Feb 2019 17:03
Last (SGD): 0.001 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.001
Buy Price - Sell Price 0.001
Buy Volume ('000) - Sell Volume ('000) 608,879.8
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00009 Trailing EPS (SGD) e -0.00010 NAV (SGD) b 0.0004
PE a - Trailing PE f - Price / NAV b 2.5000
Dividend (SGD) d - Cash In Hand (SGD) g 0.0001 Issued & Paid-up Shares c 16,174,767,000
Dividend Yield (%) d - Price / Cash In Hand g 10.000 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 16.175
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 16.450
Piotroski F Score 3 Exchange Code 5AL Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 0.0 6-Month VWAP 0.001 Free Float (%) -
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Medical Specialties
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 31 Dec 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Annica SGX 16.175 - - 2.5000 -
Industry Medical Specialties SGX 715.162 28.553 28.659 4.0737 1.704
Index FTSE ST Catalist Index SGX 84.503 - - 0.9178 1.755
Local Peer Top Glove SGX 4,122.537 28.551 28.306 5.0901 1.763
Local Peer Biolidics SGX 66.688 - - -2.5000 -
Local Peer UG Healthcare SGX 35.760 8.248 9.533 0.8533 1.258
Local Peer Yunnan Energy SGX 34.430 19.290 33.265 0.3099 -
Local Peer Medtecs Intl SGX 15.384 13.023 16.794 0.1816 -
Global Peer ABBOTT LABORATORIES NYSE 133,709.403 56.465 56.465 - -
Global Peer MEDTRONIC PLC NYSE 125,707.124 40.498 25.555 2.5228 2.068
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 101,489.410 34.544 34.544 3.6790 -
Global Peer DANAHER CORP NYSE 79,648.775 30.046 30.046 2.8230 0.564
Global Peer STRYKER CORP NYSE 70,310.706 19.789 19.789 5.9941 1.028
Global Peer BECTON DICKINSON & CO NYSE 67,174.269 422.479 75.055 3.1387 1.206
Global Peer INTUITIVE SURGICAL INC NASDAQ 63,181.900 56.017 56.017 9.4601 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 56,159.099 33.608 33.608 6.4358 -
Global Peer BAXTER INTERNATIONAL INC NYSE 39,740.290 24.471 24.471 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 35,841.713 49.628 49.629 11.4131 -
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), WATERS CORP (NYSE), IDEXX LABORATORIES INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), RESMED INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), DEXCOM INC (NASDAQ), TELEFLEX INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), STERIS PLC (NYSE), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), BIO RAD LABORATORIES INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), MASIMO CORPORATION (NASDAQ), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), ICU MEDICAL INC (NASDAQ), PENUMBRA INC (NYSE), INSULET CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), HARTA (Bursa), WEIGAO GROUP (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), CANTEL MEDICAL CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), NEOGEN CORP (NASDAQ), TOPGLOV (Bursa), INOGEN INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), QUIDEL CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), BIOTELEMETRY INC (NASDAQ), AVANOS MEDICAL INC (NYSE), EBOS GROUP (ASX), IRHYTHM TECHNOLOGIES INC (NASDAQ), CONMED CORP (NASDAQ), NXSTAGE MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MICROPORT (HKEx), ATRION CORP (NASDAQ), NEVRO CORP (NYSE), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ATRICURE INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CAREDX INC (NASDAQ), CRYOLIFE INC (NYSE), LEMAITRE VASCULAR INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), LIFETECH SCI (HKEx), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VERICEL CORP (NASDAQ), VIEWRAY INC (NASDAQ), NANOSONICS LIMITED (ASX), SURMODICS INC (NASDAQ), CIRC (HKEx), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), YESTAR HEALTH (HKEx), AK MEDICAL (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), SI BONE INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), INVACARE CORP (NYSE), GOLDEN MEDITECH (HKEx), NEURONETICS INC (NASDAQ), VAPOTHERM INC (NYSE), SIENTRA INC (NASDAQ), IRADIMED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SUPERMX (Bursa), CORINDUS VASCULAR ROBOTICS INC (NYSE American), PW MEDTECH (HKEx), NUVECTRA CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), INTRICOM CORP (NASDAQ), CRH MEDICAL CORP (NYSE American), NEMAURA MEDICAL INC (NASDAQ), ELECTROCORE INC (NASDAQ), AVEDRO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), CUTERA INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), MISONIX INC (NASDAQ), MODERN DENTAL (HKEx), MEDICAL DEVELOPMENT INTL (ASX), ZYNEX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), BIOTIME INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ONCOCYTE CORP (NYSE American), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), CORMEDIX INC (NYSE American), YUNNAN ENERGY (HKEx), STRATA SKIN SCIENCES INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), BIOSIG TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOMNOMED LIMITED (ASX), APOLLO ENDOSURGERY INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), SDI LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CAS MEDICAL SYSTEMS (NASDAQ), DAXOR CORP (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), IRIDEX CORP (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), ALPHATEC HLDGS INC (NASDAQ), IMPEDIMED LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ALPHA PRO TECH (NYSE American), CYCLOPHARM LIMITED (ASX), ENDOLOGIX INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), VIVEVE MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), BIOLASE INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), COMPUMEDICS (ASX), CELSION CORPORATION (NASDAQ), IMMUCELL CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEUROTROPE INC (NASDAQ), LIFE HEALTHCARE (HKEx), RESTORATION ROBOTICS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RESPIRI LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), CARDIEX LTD (ASX), OBJ LIMITED (ASX), MICRO-X LTD (ASX), LIANLUO SMART LIMITED (NASDAQ), NANOVIBRONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), BIOMERICA INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), CYANOTECH CORP (NASDAQ), AETHLON MEDICAL (NASDAQ), RESONANCE HEALTH LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), REWALK ROBOTICS LTD (NASDAQ), OPTISCAN IMAGING (ASX), DYNATRONICS CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), HUAKANG BIOMED (HKEx), COMBEST HOLD (HKEx), ADMEDUS LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DIGIRAD CORP (NASDAQ), ADVENTA (Bursa), AKERS BIOSCIENCES INC (NASDAQ), PRECISION THERAPEUTICS INC (NASDAQ), USCOM LTD (ASX), NEOVASC INC (NASDAQ), LKL (Bursa), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), ONE HORIZON GROUP INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), ANALYTICA (ASX), AVINGER INC (NASDAQ), SOLITON INC (NASDAQ), LBT INNOVATIONS LTD (ASX), CHECK-CAP LTD (NASDAQ), DIMERIX LTD (ASX), PRESBIA PLC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), ATOSSA GENETICS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), IMPRESSION HEALTHCARE LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), CH DEMETER FIN (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), METALICITY LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), ADHERIUM LIMITED (ASX), MEDIGARD LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MY MEDICARE (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year ---
Long Term Return 2 Years ---
3 Years ---
5 Years --0.014
-93.33 %
Annualised Return Annualised --
-41.82 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.001 - 0.001 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.001 - 0.001 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.001 - 0.017 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.016 % Change From 5 Years High (%) -94.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Singapore on 20 August 1983. On 20 March 2001, it was converted into a public limited company at which time it changed its name to Oculus Limited. It is focused on the innovation, manufacturing and marketing of colour lenses. Its colour lenses are principally marketed under the FreshKon® and Unicon™ brand names globally. Aside from colour lenses, Oculus also offers disposable daily clear lenses, disposable bi-weekly and monthly clear lenses under FreshKon® brand, and gas permeable lenses and solution under the Boston® brand to its broad customer base.With direct presence in Singapore, China, Taiwan, Hong Kong and Malaysia, its products are sold in over 50 countries globally.

IPO Performance

Listing Date 11 Apr 2001 Full Subscription Rate (x) 1.03
No of Placement Shares (M) 19.76 No of Public Offer Shares (M) 2.20 Public Offer Subscription Rate (x) 1.29
IPO Price (SGD) a 0.193 First Day Close (SGD) a 0.160 First Week Close (SGD) a 0.168
Current vs IPO Price (%) -99.48 First Day Gain (%) -17.10 First Week Gain (%) -12.95
Notes:
  1. Adjusted for the following: Rights Issue 1 for 1 @ $0.015 on 14/12/2012

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2017 Dec 2017 Part 1(0.03 MB)
Part 2(0.31 MB)
Part 3(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(0.53 MB)
Annual Report 2015 Dec 2015 Part 1(1.96 MB)
Annual Report 2014 Dec 2014 Part 1(0.78 MB)
Annual Report 2013 Dec 2013 Part 1(0.61 MB)
Annual Report 2012 Dec 2012 Part 1(0.33 MB)
Annual Report 2011 Dec 2011 Part 1(0.28 MB)
Annual Report 2010 Dec 2010 Part 1(1.97 MB)
Annual Report 2009 Dec 2009 Part 1(0.02 MB)
Part 2(0.37 MB)
Annual Report 2008 Dec 2008 Part 1(0.45 MB)
Annual Report 2007 Dec 2007 Part 1(0.70 MB)
Annual Report 2006 Dec 2006 Part 1(1.12 MB)
Annual Report 2005 Dec 2005 Part 1(6.97 MB)
IPO Prospectus
IPO Prospectus 2001 Mar 2001 Part 1(2.58 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
22 Feb 2019 0.001 0.001 0.001 0.001 - -
21 Feb 2019 0.001 0.001 0.001 0.001 - -
20 Feb 2019 0.001 0.001 0.001 0.001 800,000 0.0010
19 Feb 2019 0.001 0.001 0.001 0.001 1,200,000 0.0010
18 Feb 2019 0.001 0.001 0.001 0.001 - -
15 Feb 2019 0.001 0.001 0.001 0.001 - -
14 Feb 2019 0.001 0.001 0.001 0.001 - -
13 Feb 2019 0.001 0.001 0.001 0.001 - -
12 Feb 2019 0.001 0.001 0.001 0.001 - -
11 Feb 2019 0.001 0.001 0.001 0.001 - -
08 Feb 2019 0.001 0.001 0.001 0.001 - -
07 Feb 2019 0.001 0.001 0.001 0.001 - -
04 Feb 2019 0.001 0.001 0.001 0.001 - -
01 Feb 2019 0.001 0.001 0.001 0.001 - -
31 Jan 2019 0.001 0.001 0.001 0.001 - -
30 Jan 2019 0.001 0.001 0.001 0.001 - -
29 Jan 2019 0.001 0.001 0.001 0.001 - -
28 Jan 2019 0.001 0.001 0.001 0.001 - -
25 Jan 2019 0.001 0.001 0.001 0.001 - -
24 Jan 2019 0.001 0.001 0.001 0.001 - -
23 Jan 2019 0.001 0.001 0.001 0.001 - -
22 Jan 2019 0.001 0.001 0.001 0.001 - -
Summary
Current 2 Weeks
(11 Feb 2019 to 22 Feb 2019)
0.001 0.001 0.001 0.001 2,000,000 -
Previous 2 Weeks
(24 Jan 2019 to 08 Feb 2019)
0.001 0.001 0.001 0.001 - -
4 Weeks from
(26 Dec 2018 to 23 Jan 2019)
0.001 0.001 0.001 0.001 7,010,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.